PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis

PODO: Trial Design: Phase 2 Study of PF-06730512 in Focal Segmental Glomerulosclerosis

Introduction: Focal segmental glomerulosclerosis (FSGS) is characterized by proteinuria and a histologic pattern of glomerular lesions of diverse etiology that share features including glomerular scarring and podocyte foot process effacement. Roundabout guidance receptor 2 (ROBO2)/slit guidance liga...

Full description

Bibliographic Details
Main Authors: Laurence H. Beck, Jr., Stephen P. Berasi, J. Brian Copley, Donal Gorman, Daniel I. Levy, Chay Ngee Lim, Joel M. Henderson, David J. Salant, Weining Lu
Format: Article
Language:English
Published: Elsevier 2021-06-01
Series:Kidney International Reports
Subjects:
efficacy
focal segmental glomerulosclerosis
pharmacokinetics
ROBO2
safety
trial in progress
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024921010408

Internet

http://www.sciencedirect.com/science/article/pii/S2468024921010408

Similar Items